Amundi
KYMR icon

Amundi’s Kymera Therapeutics KYMR Stock Holding History

Amundi’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Buy
+2,988
New +$237K ﹤0.01% 1812
2025
Q2 		– Sell
-40
Closed -$948 – 1948
2025
Q1 		$948 Buy
40
+21
+111% +$766 ﹤0.01% 2044
2024
Q4 		$770 Buy
+19
New +$858 ﹤0.01% 2057
2023
Q4 		– Sell
-1,642
Closed -$20.7K – 2038
2023
Q3 		$20.7K Hold
1,642
– – ﹤0.01% 1930
2023
Q2 		$38.7K Hold
1,642
– – ﹤0.01% 1920
2023
Q1 		$49K Hold
1,642
– – ﹤0.01% 1888
2022
Q4 		$49.1K Buy
+1,642
New +$43.8K ﹤0.01% 1703

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return